141 related articles for article (PubMed ID: 21545042)
1. [Evaluation of the efficiency and reactogenicity of emulsion-based adjuvant systems in the manufacture of polyclonal enteroviral diagnostic sera].
Kozlov VG; Viktorova EG
Vopr Virusol; 2011; 56(2):41-6. PubMed ID: 21545042
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of several adjuvant emulsion regimens for the production of polyclonal antisera in rabbits.
Johnston BA; Eisen H; Fry D
Lab Anim Sci; 1991 Jan; 41(1):15-21. PubMed ID: 1849580
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of several adjuvants as alternatives to the use of Freund's adjuvant in rabbits.
Leenaars PP; Hendriksen CF; Angulo AF; Koedam MA; Claassen E
Vet Immunol Immunopathol; 1994 Mar; 40(3):225-41. PubMed ID: 8160361
[TBL] [Abstract][Full Text] [Related]
5. Syntex adjuvant formulation.
Allison AC; Byars NE
Res Immunol; 1992 Jun; 143(5):519-25. PubMed ID: 1439132
[No Abstract] [Full Text] [Related]
6. The selection of an adjuvant emulsion for polyclonal antibody production using a low-molecular-weight antigen in rabbits.
Smith DE; O'Brien ME; Palmer VJ; Sadowski JA
Lab Anim Sci; 1992 Dec; 42(6):599-601. PubMed ID: 1479813
[TBL] [Abstract][Full Text] [Related]
7. Immunological response of female macaques to the PH-20 sperm protein following injection of recombinant proteins or synthesized peptides.
Deng X; Meyers SA; Tollner TL; Yudin AI; Primakoff PD; He DN; Overstreet JW
J Reprod Immunol; 2002 Mar; 54(1-2):93-115. PubMed ID: 11839398
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Montanide adjuvants, IMS 3012 (Nanoparticle), ISA 206 and ISA 35 (Emulsion based) along with incomplete Freund's adjuvant for hyperimmunization of equines used for production of polyvalent snake antivenom.
Waghmare A; Deopurkar RL; Salvi N; Khadilkar M; Kalolikar M; Gade SK
Vaccine; 2009 Feb; 27(7):1067-72. PubMed ID: 19100805
[TBL] [Abstract][Full Text] [Related]
9. Immune responses induced by prototype vaccines for AIDS in rhesus monkeys.
Ohkawa S; Wilson LA; Larosa G; Javaherian K; Martin LN; Murphey-Corb M
AIDS Res Hum Retroviruses; 1994 Jan; 10(1):27-38. PubMed ID: 8179961
[TBL] [Abstract][Full Text] [Related]
10. Immune responses and side effects of five different oil-based adjuvants in mice.
Leenaars M; Koedam MA; Hendriksen CF; Claassen E
Vet Immunol Immunopathol; 1998 Feb; 61(2-4):291-304. PubMed ID: 9613442
[TBL] [Abstract][Full Text] [Related]
11. [Adjuvants: update on concepts].
Berinstein A; Sadir AM
Rev Argent Microbiol; 1990; 22(3):159-66. PubMed ID: 2102016
[No Abstract] [Full Text] [Related]
12. A comparison of commercially available adjuvants for use in research.
Bennett B; Check IJ; Olsen MR; Hunter RL
J Immunol Methods; 1992 Aug; 153(1-2):31-40. PubMed ID: 1517600
[TBL] [Abstract][Full Text] [Related]
13. Mixed adjuvant formulations reveal a new combination that elicit antibody response comparable to Freund's adjuvants.
Lai RP; Seaman MS; Tonks P; Wegmann F; Seilly DJ; Frost SD; LaBranche CC; Montefiori DC; Dey AK; Srivastava IK; Sattentau Q; Barnett SW; Heeney JL
PLoS One; 2012; 7(4):e35083. PubMed ID: 22509385
[TBL] [Abstract][Full Text] [Related]
14. Comparison of immune and adverse effects induced by AdjuVac and Freund's complete adjuvant in New Zealand white rabbits (Oryctolagus cuniculus).
Powers JG; Nash PB; Rhyan JC; Yoder CA; Miller LA
Lab Anim (NY); 2007 Oct; 36(9):51-8. PubMed ID: 17885664
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Freund's adjuvant and TiterMax in inducing anti-idiotype to idiotypic antibodies against pseudorabies virus antigens.
Zhou EM; Afshar A
Vet Immunol Immunopathol; 1995 Sep; 48(1-2):113-22. PubMed ID: 8533307
[TBL] [Abstract][Full Text] [Related]
16. [Rational method for producing sera with high titers of virus-neutralizing antibodies. Part III].
Kravchenko AT; Tsetlin EM; Omel'chenko TN
Zh Mikrobiol Epidemiol Immunobiol; 1980 Jul; (7):50-4. PubMed ID: 6254289
[TBL] [Abstract][Full Text] [Related]
17. The effect of adjuvants on the efficacy of a recombinant herpes simplex virus glycoprotein vaccine.
Sanchez-Pescador L; Burke RL; Ott G; Van Nest G
J Immunol; 1988 Sep; 141(5):1720-7. PubMed ID: 2842401
[TBL] [Abstract][Full Text] [Related]
18. Freund's complete adjuvant: an effective but disagreeable formula.
Claassen E; de Leeuw W; de Greeve P; Hendriksen C; Boersma W
Res Immunol; 1992 Jun; 143(5):478-83; discussion 572. PubMed ID: 1439126
[No Abstract] [Full Text] [Related]
19. Mechanisms of action by immunologic adjuvants.
Osebold JW
J Am Vet Med Assoc; 1982 Nov; 181(10):983-7. PubMed ID: 6294032
[No Abstract] [Full Text] [Related]
20. The effect of Syntex adjuvant formulation (SAF-m) on humoral immunity to the influenza virus in the mouse.
Hjorth RN; Bonde GM; Piner ED; Goldberg KM; Levner MH
Vaccine; 1997 Apr; 15(5):541-6. PubMed ID: 9160522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
